Stability and Visual Compatibility of Daunorubicin and Cytarabine During Y-site Administration with Selected Drugs.
Journal of clinical oncology(2020)
Abstract
e15516Background: Vyxeos is a daunorubicine plus cytarabine liposome indicated in adults patient with newly diagnosed acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) and therap...
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined